2011 annual financial data
Summit Therapeutics 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -340.57%.
Operating income was -4,714,047 GBP and net income was -4,230,394 GBP.
Operating cash flow was -3,801,702 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,116,274 GBP
- Operating income
- -4,714,047 GBP
- Net income
- -4,230,394 GBP
- Operating cash flow
- -3,801,702 GBP